Literature DB >> 11327646

Use of valnemulin in the control of Mycoplasma bovis infection under field conditions.

L Stipkovits1, P H Ripley, J Varga, V Palfi.   

Abstract

In a blind trial, alternate calves in six consecutive production batches of calves (total 70), on a farm with a high incidence of respiratory and reproductive disease, were allocated to treatment with either valnemulin or a placebo premix added to the milk from four days of age. The calves were weighed at the beginning and end of a 21-day period of medication. Blood samples and nasal swabs were taken and examined for the presence of Mycoplasma and Pasteurella species, and antibodies to viral agents. Clinical condition, rectal temperature, respiratory and other signs and refusals of milk were recorded daily. Dead calves were examined postmortem. The calves medicated with valnemulin gained weight more quickly, had fewer cases of Mycoplasma infection and fewer respiratory signs, and required fewer treatments with antibiotics than those in the placebo group.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11327646     DOI: 10.1136/vr.148.13.399

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  7 in total

1.  Oral inoculation of young dairy calves with Mycoplasma bovis results in colonization of tonsils, development of otitis media and local immunity.

Authors:  Fiona Maunsell; Mary B Brown; Joshua Powe; James Ivey; Matthew Woolard; Wees Love; Jerry W Simecka
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

2.  In vitro and in vivo metabolite profiling of valnemulin using ultraperformance liquid chromatography-quadrupole/time-of-flight hybrid mass spectrometry.

Authors:  Shupeng Yang; Weimin Shi; Dingfei Hu; Suxia Zhang; Huiyan Zhang; Zhanhui Wang; Linli Cheng; Feifei Sun; Jianzhong Shen; Xingyuan Cao
Journal:  J Agric Food Chem       Date:  2014-09-02       Impact factor: 5.279

3.  Field evaluation of a Mycoplasma bovis bacterin in young dairy calves.

Authors:  Fiona P Maunsell; G Arthur Donovan; Carlos Risco; Mary B Brown
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

4.  An experimental vaccine for calf pneumonia caused by Mycoplasma bovis: clinical, cultural, serological and pathological findings.

Authors:  Robin A J Nicholas; Roger D Ayling; Laszlo P Stipkovits
Journal:  Vaccine       Date:  2002-10-04       Impact factor: 3.641

5.  Etiology of respiratory disease in non-vaccinated, non-medicated calves in rearing herds.

Authors:  T Autio; T Pohjanvirta; R Holopainen; U Rikula; J Pentikäinen; A Huovilainen; H Rusanen; T Soveri; L Sihvonen; S Pelkonen
Journal:  Vet Microbiol       Date:  2006-10-12       Impact factor: 3.293

Review 6.  Mycoplasma bovis: Mechanisms of Resistance and Trends in Antimicrobial Susceptibility.

Authors:  Inna Lysnyansky; Roger D Ayling
Journal:  Front Microbiol       Date:  2016-04-27       Impact factor: 5.640

Review 7.  Biosecurity and risk management for dairy replacements.

Authors:  Fiona Maunsell; G Arthur Donovan
Journal:  Vet Clin North Am Food Anim Pract       Date:  2008-03       Impact factor: 3.357

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.